Company news

01 October 2019

Alkor Bio Group of Companies received the RF Healthcare Supervision Service of the Russian Federation for a kit of reagents for detecting DNA of microorganisms of the genus Ureaplasma by real-time PCR

In late August, Alkor Bio Group of Companies - the developer and manufacturer of test systems for laboratory diagnostics by ELISA and PCR methods - received a registration certificate from the Russian Healthcare Agency for its new kit of “Intifica Ureaplasma species” for detecting DNA of microorganisms of the genus Ureaplasma (U. parvum, U. urealyticum) by PCR with hybridization-fluorescence detection in real time.

 Ureaplasmas  can cause inflammation of any part of the genitourinary tract - the urethra, prostate, bladder, testicles and their appendages, and in women body - the vagina, uterus and appendages, as well as joint inflammation, especially with rheumatoid arthritis. In addition, some studies have shown that ureaplasmas can be fixed on spermatozoa and disrupt their motor activity, and in some cases just kill sperm. The key to successful treatment of ureaplasmosis is timely and accurate diagnosis.

The kits are intended for the qualitative determination of DNA of these pathogens in nucleic acid preparations obtained using Alkor Bio DNA extraction kits from clinical samples of smears / scrapings from the mucous membranes of the urogenital tract (urethra, cervical canal and vagina) and first urine samples by PCR in real time. The high sensitivity and relative simplicity of the PCR analysis with the detection of amplification products in real time makes it possible to widely use PCR to diagnose and monitor the effectiveness of the treatment of sexually transmitted infections (STIs).

The Intifica Ureaplasma species reagent kit can be used in clinical laboratory diagnostics to identify carriers of STI pathogens of the genus Ureaplasma (U. parvum, U. urealyticum.), Which is especially important when planning pregnancy, studying the causes of infertility, as well as inflammatory processes in the urogenital tract . When using this kit, cross-reactions with closely related microorganisms and other infectious pathogens are excluded.

Recall that earlier Alkor Bio Group of Companies was developed, registered in the Russian Healthcare Supervision Service and released to the market reagent kits for the diagnosis of gonorrhea, trichomoniasis and chlamydia using real-time PCR. At present, Alkor Bio Group of Companies in the direction of “Infectious Diagnostics” produces reagent kits for the detection of HIV, hepatitis B and C, infections of the TORCH complex, syphilis, and STIs. In total, the catalog of the company has test systems for ELISA and PCR more than a hundred items.